drugset
drugset / Trial / NCT03109418

Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea

NCT03109418 ↗

Phase 2/3 Terminated 9 enrolled University of Alabama at Birmingham
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this study is to substantially reduce overall postoperative morbidity and mortality associated with obstructive sleep apnea.

Timeline

Start
2016-06-02
Primary completion
2018-09-12
Completion
2018-09-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule — —

Indications

obstructive sleep apnea syndrome